sign free newsletters sign free newsletters gene editing technology cancer treatment safety test start later year crispr genome editing technology finally nearing human trials june 21 advisory committee national institutes health nih approved proposal use crispr cas9 help augment cancer therapies rely enlisting patient t cells type immune cell cell therapies cancer promising majority people therapies disease relapses says study leader physician university pennsylvania philadelphia gene editing improve treatments eliminate vulnerabilities cancer body immune system says trial small designed test crispr safe use people cures cancer funded $ 250 million immunotherapy foundation formed april facebook president sean parker trial not